MPLN Share Price | MultiPlan Corp. Stock Analysis & Recommendation

Q: How big is MultiPlan Corp.?

Market Cap: As of Jun 18, MultiPlan Corp. has a market capitalization of 1,444.25 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, MultiPlan Corp. reported net sales of 927.46 million and a net profit of -1,177.47 million.Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 84.02 million and total assets of 5,344.19 million.

Q: What does MultiPlan Corp. do?

Overview: MultiPlan Corp. is a provider of data analytics and technology-enabled end-to-end cost management solutions to the healthcare industry, operating within the Commercial Services & Supplies sector and classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 231 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -71 Million (Quarterly Results - Mar 2025) Market-cap: USD 1,444.25 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 309.27 Return on Equity: -896.41% Price to Book: 97.42Contact Details: Address: 115 Fifth Avenue, NEW YORK NY: 10003 Tel: 1 212 3807500 Website: https://iii.churchillcapitalcorp.com/

Q: Is MultiPlan Corp. overvalued or undervalued?

As of 28 February 2023, the valuation grade for MultiPlan Corp. has moved from attractive to risky, indicating a shift in perception regarding its financial health and investment potential. The company appears to be overvalued, particularly given its high Price to Book Value of 95.80 and an EV to EBITDA ratio of 11.63, which are significantly elevated compared to industry norms. Additionally, the ROE is alarmingly low at -896.41%, suggesting severe inefficiencies in generating returns for shareholders.In comparison to peers, MultiPlan Corp. shows a P/E ratio of -15.00, while Kyndryl Holdings, Inc. and ExlService Holdings, Inc. have P/E ratios of 31.33 and 31.10, respectively, highlighting a stark contrast in valuation metrics. The company’s recent stock performance has been mixed; while it has posted a remarkable YTD return of 274.76%, it has also experienced a significant decline of -23.27% over the past month, contrasting sharply with the S&P 500's 2.33% gain during the same period. This volatility underscores the risks associated with investing in MultiPlan Corp. at its current valuation.

Q: Is MultiPlan Corp. technically bullish or bearish?

As of 4 September 2025, the technical trend for MultiPlan Corp. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames. Daily moving averages are also mildly bullish. However, the KST shows a mildly bearish signal on the weekly, though it is bullish monthly, and Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend. In terms of performance, MultiPlan has significantly outperformed the S&P 500 year-to-date with a return of 274.76% compared to the S&P 500's 12.22%, and over the past year, it has returned 488.50% against the S&P 500's 17.14%. Overall, the current technical stance is bullish, driven primarily by the weekly MACD and the Bollinger Bands.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

48.76 k

Shareholding (Mar 2026)

FII

18.92%

Held by 70 FIIs

DII

28.19%

Held by 14 DIIs

Promoter

40.03%

How big is MultiPlan Corp.?

22-Jun-2025

As of Jun 18, MultiPlan Corp. has a market capitalization of 1,444.25 million, with net sales of 927.46 million and a net profit of -1,177.47 million over the latest four quarters.

View full answer

What does MultiPlan Corp. do?

22-Jun-2025

MultiPlan Corp. provides data analytics and cost management solutions for the healthcare industry, with recent net sales of $231 million and a net loss of $71 million. It has a market cap of approximately $1.44 billion and operates as a micro-cap company.

View full answer

Is MultiPlan Corp. overvalued or undervalued?

20-Sep-2025

As of February 28, 2023, MultiPlan Corp. is considered a risky investment due to its overvaluation indicated by a high Price to Book Value of 95.80, a low ROE of -896.41%, and a P/E ratio of -15.00, despite a strong YTD return of 274.76 and recent volatility.

View full answer

Is MultiPlan Corp. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, MultiPlan Corp. shows a bullish technical trend, supported by a bullish weekly MACD and Bollinger Bands, despite some mixed signals from the KST and Dow Theory, while significantly outperforming the S&P 500 with a year-to-date return of 274.76%.

View full answer

Compare MultiPlan Corp. with Similar Stocks

Global Blue Group Holding AG AvePoint, Inc.Sterling Check Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.12%

Low ability to service debt as the company has a high Debt to EBITDA ratio of 12.46 times

With a fall in Operating Profit of -0.29%, the company declared Very Negative results in Jun 25

Risky -

Mojo Parameters

Stock DNA

Industry

Commercial Services & Supplies

Market cap

USD 634 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-45.03

Return on Equity

209.59%

Price to Book

-6.22

Revenue and Profits:

Net Sales:

245 Million

(Quarterly Results - Mar 2026)

Net Profit:

-74 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

4.21%

6 Months

-61.01%

1 Year

25.12%

2 Years

11.17%

3 Years

3350.48%

4 Years

-84.83%

5 Years

-90.34%

MultiPlan Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.86%

EBIT Growth (5y)

20.92%

EBIT to Interest (avg)

0.74

Debt to EBITDA (avg)

12.46

Net Debt to Equity (avg)

309.27

Sales to Capital Employed (avg)

0.18

Tax Ratio

9.35%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

92.30%

ROCE (avg)

3.12%

ROE (avg)

1.16%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-6.22

EV to EBIT

102.75

EV to EBITDA

10.51

EV to Capital Employed

1.16

EV to Sales

5.49

PEG Ratio

Dividend Yield

ROCE (Latest)

1.13%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 32 Schemes (12.87%)

Foreign Institutions

Held by 70 Foreign Institutions (18.92%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -0.77% vs 0.24% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 8.68% vs -15.47% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "244.70",
          "val2": "246.60",
          "chgp": "-0.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "118.30",
          "val2": "113.60",
          "chgp": "4.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "97.90",
          "val2": "97.50",
          "chgp": "0.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-73.60",
          "val2": "-80.60",
          "chgp": "8.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.30%",
          "val2": "5.30%",
          "chgp": "2.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.74% vs -3.21% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 82.73% vs -1,694.77% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "965.40",
          "val2": "930.60",
          "chgp": "3.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "494.10",
          "val2": "538.10",
          "chgp": "-8.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "389.50",
          "val2": "331.40",
          "chgp": "17.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.30",
          "val2": "-1,549.10",
          "chgp": "99.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-284.30",
          "val2": "-1,645.80",
          "chgp": "82.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.30%",
          "val2": "109.20%",
          "chgp": "-6.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

244.70

246.60

-0.77%

Operating Profit (PBDIT) excl Other Income

118.30

113.60

4.14%

Interest

97.90

97.50

0.41%

Exceptional Items

0.00

-0.20

100.00%

Consolidate Net Profit

-73.60

-80.60

8.68%

Operating Profit Margin (Excl OI)

27.30%

5.30%

2.20%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -0.77% vs 0.24% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 8.68% vs -15.47% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

965.40

930.60

3.74%

Operating Profit (PBDIT) excl Other Income

494.10

538.10

-8.18%

Interest

389.50

331.40

17.53%

Exceptional Items

-9.30

-1,549.10

99.40%

Consolidate Net Profit

-284.30

-1,645.80

82.73%

Operating Profit Margin (Excl OI)

47.30%

109.20%

-6.19%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.74% vs -3.21% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 82.73% vs -1,694.77% in Dec 2024

All Annual Results

Company CV

About MultiPlan Corp.

MultiPlan Corp.

Commercial Services & Supplies

MultiPlan Corporation, formerly Churchill Capital Corp III, is a provider of data analytics and technology-enabled end-to-end cost management solutions to the healthcare industry. The Company's services include medical payment integrity, dental payment integrity, network-based services and analytics-based services. Leveraging technology and data analytics, the Company interprets clients’ needs and customizes solutions. Its medical payment integrity service combines automation with clinical review. The Company's dental payment integrity services offer an automated, pre-payment detection system that targets all claims. Its intelligent algorithms mimic the outcome of a review by a dentist trained in informatics and forensics. It contracts with healthcare providers to offer network-based services. The Company's analytics-based services takes cues from the data to customize solutions for out-of-network healthcare cost management.

Company Coordinates

Company Details

115 Fifth Avenue , NEW YORK NY : 10003

Tel: 1 212 3807500

https://iii.churchillcapitalcorp.com/

Registrar Details